SO
BCRX icon

STRS Ohio’s BioCryst Pharmaceuticals BCRX Stock Holding History

STRS Ohio’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,700
Closed -$309K – 2186
2025
Q3 		$309K Hold
40,700
– – ﹤0.01% 1320
2025
Q2 		$365K Buy
40,700
+2,900
+8% +$27K ﹤0.01% 1435
2025
Q1 		$284K Buy
37,800
+29,500
+355% +$238K ﹤0.01% 1423
2024
Q4 		$62.4K Buy
+8,300
New +$63K ﹤0.01% 1701
2022
Q4 		– Sell
-1,500
Closed -$18K – 1984
2022
Q3 		$18K Buy
+1,500
New +$19.3K ﹤0.01% 1934
2022
Q2 		– Sell
-2,000
Closed -$32K – 2052
2022
Q1 		$32K Buy
+2,000
New +$32.1K ﹤0.01% 1999
2021
Q4 		– Sell
-3,400
Closed -$48K – 2200
2021
Q3 		$48K Buy
+3,400
New +$53.6K ﹤0.01% 2075
2020
Q3 		– Sell
-16,400
Closed -$78K – 2194
2020
Q2 		$78K Buy
+16,400
New +$65.5K ﹤0.01% 1835

Other funds holding BCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return